Conceptio › Archive › Scholar Commons
Scholar Commonsmetadata only

Cost-Effectiveness Analysis of Aducanumab Versus Placebo for Patients With Mild Cognitive Impairment and Mild Alzheimer’s Disease

Xiong, Xiaomo et al.
Scholar Commons · Other
Open Source ↗
alzheimersdiseasecost
aducanumab, alzheimer's disease, mild cognitive impairment, mci, mild alzheimer's disease, cost-effectiveness analysis, health economics, markov model
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 450522
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.